Evidence map›Paper›PMID 20040675›Full record

ArticleDiabetes care2010

Altered C-fiber function as an indicator of early peripheral neuropathy in individuals with impaired glucose tolerance.

Alistair Q Green, Singhan Krishnan, Francis M Finucane, Gerry Rayman

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Diabetes care, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02549534 (Early Detection of Taxane-Induced Neuropathy in Women With Breast Cancer), which is not on this map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02549534 completednot on this mapstarted 2015, after this paper: background citation

Early Detection of Taxane-Induced Neuropathy in Women With Breast Cancer

TypeobservationalSponsorIndiana UniversityRan2015 to 2016Enrolled29ConditionsPeripheral NeuropathyArmsAxon Reflexes, Axon Flares, Self-Reported Signs & Symptoms of CIPN
3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 88 citations in OpenAlex.

  1. Trial
  2. Article
  3. Indole metabolism and its role in diabetic macrovascular and microvascular complications.American heart journal plus : cardiology research and practice · 2025
    Review
  4. Role of microglia in diabetic neuropathic pain.Frontiers in cell and developmental biology · 2024
    Review
  5. Alleviative Effect ofPlants (Basel, Switzerland) · 2023
    Article
  6. The foot in diabetes - a reminder of an ever-present risk.Clinical medicine (London, England) · 2023
    Review
  7. Application of SygenBioengineering (Basel, Switzerland) · 2022
    Review
  8. Small Fiber Neuropathy in Diabetes Polyneuropathy: Is It Time to Change?Journal of diabetes science and technology · 2022
    Review
  9. Review
  10. Review
  11. Cutaneous innervation in impaired diabetic wound healing.Translational research : the journal of laboratory and clinical medicine · 2021
    Review
  12. Review
  13. Review
  14. Is there cardiac autonomic neuropathy in prediabetes?Autonomic neuroscience : basic & clinical · 2020
    Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Cardiac Autonomic Neuropathy in Obesity, the Metabolic Syndrome and Prediabetes: A Narrative Review.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2019 · on this map
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Alistair Q GreenThe Diabetes Research Centre, Ipswich Hospital National Health Service Trust, Suffolk, UK.
Singhan Krishnan
Francis M Finucane
Gerry Rayman
National Health Service · GBIpswich Hospital · GBMedical Research Council · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study explored the importance of glycemic burden compared with features of the metabolic syndrome in the pathogenesis of diabetic neuropathy by comparing C-fiber function in people with type 1 diabetes to that in people with impaired glucose tolerance (IGT). RESEARCH DESIGN AND

methodsThe axon reflex-elicited flare areas (LDIflares) were measured with a laser Doppler imager (LDI) in age-, height-, and BMI-matched groups with IGT (n = 14) and type 1 diabetes (n = 16) and in healthy control subjects (n = 16).

resultsThe flare area was reduced in the IGT group compared with the control (2.78 +/- 1.1 vs. 5.23 +/- 1.7 cm(2), P = 0.0001) and type 1 diabetic (5.16 +/- 2.3 cm(2), P = 0.002) groups, whereas the flare area was similar in the type 1 diabetic and control groups.

conclusionsThis technique suggests that small-fiber neuropathy is a feature of IGT. The absence of similar small-fiber neuropathy in those with longstanding type 1 diabetes suggests that glycemia may not be the major determinant of small-fiber neuropathy in IGT.

Indexed as

AdultCase-Control StudiesDiabetic NeuropathiesDiagnostic Techniques, NeurologicalFemaleGlucose IntoleranceHumansMaleMiddle AgedNerve Fibers, UnmyelinatedPeripheral Nervous System Diseases

Identifiers

PMID20040675
PMCPMC2797968
OpenAlexW1965175303

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.